Bronchopulmonary Dysplasia
A chronic lung disease developed after OXYGEN INHALATION THERAPY or mechanical ventilation (VENTILATION, MECHANICAL) usually occurring in certain premature infants (INFANT, PREMATURE) or newborn infants with respiratory distress syndrome (RESPIRATORY DISTRESS SYNDROME, NEWBORN). Histologically, it is characterized by the unusual abnormalities of the bronchioles, such as METAPLASIA, decrease in alveolar number, and formation of CYSTS.
Aspergillosis, Allergic Bronchopulmonary
Infant, Very Low Birth Weight
Respiratory Distress Syndrome, Newborn
A condition of the newborn marked by DYSPNEA with CYANOSIS, heralded by such prodromal signs as dilatation of the alae nasi, expiratory grunt, and retraction of the suprasternal notch or costal margins, mostly frequently occurring in premature infants, children of diabetic mothers, and infants delivered by cesarean section, and sometimes with no apparent predisposing cause.
Infant, Extremely Low Birth Weight
Gestational Age
Bronchopulmonary Sequestration
A developmental anomaly in which a mass of nonfunctioning lung tissue lacks normal connection with the tracheobroncheal tree and receives an anomalous blood supply originating from the descending thoracic or abdominal aorta. The mass may be extralobar, i.e., completely separated from normally connected lung, or intralobar, i.e., partly surrounded by normal lung.
Lung
Respiration, Artificial
Any method of artificial breathing that employs mechanical or non-mechanical means to force the air into and out of the lungs. Artificial respiration or ventilation is used in individuals who have stopped breathing or have RESPIRATORY INSUFFICIENCY to increase their intake of oxygen (O2) and excretion of carbon dioxide (CO2).
Intensive Care Units, Neonatal
Oxygen Inhalation Therapy
Fibrous Dysplasia of Bone
Ureaplasma urealyticum
Chorioamnionitis
Pulmonary Surfactants
Respiratory Aspiration
Pulmonary Alveoli
Intensive Care, Neonatal
Ectodermal Dysplasia
A group of hereditary disorders involving tissues and structures derived from the embryonic ectoderm. They are characterized by the presence of abnormalities at birth and involvement of both the epidermis and skin appendages. They are generally nonprogressive and diffuse. Various forms exist, including anhidrotic and hidrotic dysplasias, FOCAL DERMAL HYPOPLASIA, and aplasia cutis congenita.
Papio
A genus of the subfamily CERCOPITHECINAE, family CERCOPITHECIDAE, consisting of five named species: PAPIO URSINUS (chacma baboon), PAPIO CYNOCEPHALUS (yellow baboon), PAPIO PAPIO (western baboon), PAPIO ANUBIS (or olive baboon), and PAPIO HAMADRYAS (hamadryas baboon). Members of the Papio genus inhabit open woodland, savannahs, grassland, and rocky hill country. Some authors consider MANDRILLUS a subgenus of Papio.
Lung Injury
Ureaplasma
Leukomalacia, Periventricular
Degeneration of white matter adjacent to the CEREBRAL VENTRICLES following cerebral hypoxia or BRAIN ISCHEMIA in neonates. The condition primarily affects white matter in the perfusion zone between superficial and deep branches of the MIDDLE CEREBRAL ARTERY. Clinical manifestations include VISION DISORDERS; CEREBRAL PALSY; PARAPLEGIA; SEIZURES; and cognitive disorders. (From Adams et al., Principles of Neurology, 6th ed, p1021; Joynt, Clinical Neurology, 1997, Ch4, pp30-1)
Infant, Low Birth Weight
Developmental Disabilities
Disorders in which there is a delay in development based on that expected for a given age level or stage of development. These impairments or disabilities originate before age 18, may be expected to continue indefinitely, and constitute a substantial impairment. Biological and nonbiological factors are involved in these disorders. (From American Psychiatric Glossary, 6th ed)
Ambroxol
Trachea
Retinopathy of Prematurity
A bilateral retinopathy occurring in premature infants treated with excessively high concentrations of oxygen, characterized by vascular dilatation, proliferation, and tortuosity, edema, and retinal detachment, with ultimate conversion of the retina into a fibrous mass that can be seen as a dense retrolental membrane. Usually growth of the eye is arrested and may result in microophthalmia, and blindness may occur. (Dorland, 27th ed)
Aspergillus fumigatus
Sucking Behavior
Consensus Development Conferences, NIH as Topic
Articles on conferences sponsored by NIH presenting summary statements representing the majority agreement of physicians, scientists, and other professionals convening for the purpose of reaching a consensus on a subject of interest. This heading is used for NIH consensus conferences as a means of scientific communication. In indexing it is viewed as a type of review article and as a tag for any article appearing in any publication of the NIH Office of Medical Applications of Research (OMAR).
Ductus Arteriosus, Patent
Apgar Score
A method, developed by Dr. Virginia Apgar, to evaluate a newborn's adjustment to extrauterine life. Five items - heart rate, respiratory effort, muscle tone, reflex irritability, and color - are evaluated 60 seconds after birth and again five minutes later on a scale from 0-2, 0 being the lowest, 2 being normal. The five numbers are added for the Apgar score. A score of 0-3 represents severe distress, 4-7 indicates moderate distress, and a score of 7-10 predicts an absence of difficulty in adjusting to extrauterine life.
Premature Birth
Hyaline Membrane Disease
A respiratory distress syndrome in newborn infants, usually premature infants with insufficient PULMONARY SURFACTANTS. The disease is characterized by the formation of a HYALINE-like membrane lining the terminal respiratory airspaces (PULMONARY ALVEOLI) and subsequent collapse of the lung (PULMONARY ATELECTASIS).
Birth Weight
Maximal Expiratory Flow Rate
Pregnancy
Functional Residual Capacity
Uterine Cervical Dysplasia
Fibromuscular Dysplasia
An idiopathic, segmental, nonatheromatous disease of the musculature of arterial walls, leading to STENOSIS of small and medium-sized arteries. There is true proliferation of SMOOTH MUSCLE CELLS and fibrous tissue. Fibromuscular dysplasia lesions are smooth stenosis and occur most often in the renal and carotid arteries. They may also occur in other peripheral arteries of the extremity.
Intermittent Positive-Pressure Ventilation
Continuous Positive Airway Pressure
A technique of respiratory therapy, in either spontaneously breathing or mechanically ventilated patients, in which airway pressure is maintained above atmospheric pressure throughout the respiratory cycle by pressurization of the ventilatory circuit. (On-Line Medical Dictionary [Internet]. Newcastle upon Tyne(UK): The University Dept. of Medical Oncology: The CancerWEB Project; c1997-2003 [cited 2003 Apr 17]. Available from: http://cancerweb.ncl.ac.uk/omd/)
Suction
Psychomotor Disorders
Administration, Inhalation
Bronchoalveolar Lavage Fluid
Ventilator Weaning
Techniques for effecting the transition of the respiratory-failure patient from mechanical ventilation to spontaneous ventilation, while meeting the criteria that tidal volume be above a given threshold (greater than 5 ml/kg), respiratory frequency be below a given count (less than 30 breaths/min), and oxygen partial pressure be above a given threshold (PaO2 greater than 50mm Hg). Weaning studies focus on finding methods to monitor and predict the outcome of mechanical ventilator weaning as well as finding ventilatory support techniques which will facilitate successful weaning. Present methods include intermittent mandatory ventilation, intermittent positive pressure ventilation, and mandatory minute volume ventilation.
Retrospective Studies
Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons.
Disease Models, Animal
Fatty Alcohols
Usually high-molecular-weight, straight-chain primary alcohols, but can also range from as few as 4 carbons, derived from natural fats and oils, including lauryl, stearyl, oleyl, and linoleyl alcohols. They are used in pharmaceuticals, cosmetics, detergents, plastics, and lube oils and in textile manufacture. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed)
Respiratory Function Tests
Fibrous Dysplasia, Polyostotic
Fetus
Lung Diseases, Fungal
Oxygen
Enterocolitis, Necrotizing
Prospective Studies
Hip Dysplasia, Canine
Cleidocranial Dysplasia
Retinal Dysplasia
Infant, Newborn, Diseases
Diseases of newborn infants present at birth (congenital) or developing within the first month of birth. It does not include hereditary diseases not manifesting at birth or within the first 30 days of life nor does it include inborn errors of metabolism. Both HEREDITARY DISEASES and METABOLISM, INBORN ERRORS are available as general concepts.
Cerebral Palsy
A heterogeneous group of nonprogressive motor disorders caused by chronic brain injuries that originate in the prenatal period, perinatal period, or first few years of life. The four major subtypes are spastic, athetoid, ataxic, and mixed cerebral palsy, with spastic forms being the most common. The motor disorder may range from difficulties with fine motor control to severe spasticity (see MUSCLE SPASTICITY) in all limbs. Spastic diplegia (Little disease) is the most common subtype, and is characterized by spasticity that is more prominent in the legs than in the arms. Pathologically, this condition may be associated with LEUKOMALACIA, PERIVENTRICULAR. (From Dev Med Child Neurol 1998 Aug;40(8):520-7)
Risk Factors
Follow-Up Studies
Hip Dislocation, Congenital
Early inhaled glucocorticoid therapy to prevent bronchopulmonary dysplasia. (1/452)
BACKGROUND: The safety and efficacy of inhaled glucocorticoid therapy for asthma stimulated its use in infants to prevent bronchopulmonary dysplasia. We tested the hypothesis that early therapy with inhaled glucocorticoids would decrease the frequency of bronchopulmonary dysplasia in premature infants. METHODS: We conducted a randomized, multicenter trial of inhaled beclomethasone or placebo in 253 infants, 3 to 14 days old, born before 33 weeks of gestation and weighing 1250 g or less at birth, who required ventilation therapy. Beclomethasone was delivered in a decreasing dosage, from 40 to 5 microg per kilogram of body weight per day, for four weeks. The primary outcome measure was bronchopulmonary dysplasia at 28 days of age. Secondary outcomes included bronchopulmonary dysplasia at 36 weeks of postmenstrual age, the need for systemic glucocorticoid therapy, the need for bronchodilator therapy, the duration of respiratory support, and death. RESULTS: One hundred twenty-three infants received beclomethasone, and 130 received placebo. The frequency of bronchopulmonary dysplasia was similar in the two groups: 43 percent in the beclomethasone group and 45 percent in the placebo group at 28 days of age, and 18 percent in the beclomethasone group and 20 percent in the placebo group at 36 weeks of postmenstrual age. At 28 days of age, fewer infants in the beclomethasone group than in the placebo group were receiving systemic glucocorticoid therapy (relative risk, 0.6; 95 percent confidence interval, 0.4 to 1.0) and mechanical ventilation (relative risk, 0.8; 95 percent confidence interval, 0.6 to 1.0). CONCLUSIONS: Early beclomethasone therapy did not prevent bronchopulmonary dysplasia but was associated with lower rates of use of systemic glucocorticoid therapy and mechanical ventilation. (+info)Effect of early ambroxol treatment on lung functions in mechanically ventilated preterm newborns who subsequently developed a bronchopulmonary dysplasia (BPD). (2/452)
In a randomized trial in 102 preterm newborns with respiratory distress syndrome (RDS) it has been shown that early Ambroxol treatment (30 mg kg(-1) over the first 5 days) significantly reduces the incidence of RDS-associated complications [bronchopulmonary dysplasia (BPD), intraventricular haemorrhage, post-natal acquired pneumonia]. The aim of the present analysis was to investigate the effect of Ambroxol treatment on lung function in newborns who developed BPD. Respiratory function testing (RFT) was performed immediately after extubation and at day 28. Tidal volume (VT) and respiratory frequency (f) were measured during tidal breathing using the deadspace free flow-through technique. The lung mechanic parameter VT/maxPes was determined by measuring the maximal oesophageal pressure changes, maxPes, with a catheter tip pressure transducer. In the placebo group 36/50 infants were extubated within the first 28 days of life and 13/36 (36%) developed BPD. In the Ambroxol group 44/52 were extubated and 9/44 (20%) developed BPD. After extubation, RFT showed (i) no statistically significant difference in the ventilatory parameters of either treatment group, (ii) improved (P<0.05) lung mechanics (VT/maxPes) in Ambroxol group compared to controls (94+/-27 ml kPa(-1) vs. 8.1+/-2.6 ml kPa(-1)) and (iii) no statistically significant difference in lung function between infants with and without BPD. At day 28 we found (i) no effect of early Ambroxol treatment on lung functions, (ii) significantly (P < 0.05) higher f (58.5+/-11.7 min(-1) vs. 49.7+/-10.1 min(-1)) and significantly (P<0.01) lower V(T) (9.6+/-1.9 ml vs. 12.3+/-2.7 ml) and V(T)/maxPes (8.9+/-2.6 ml kPa(-1)] vs. 12.0+/-2.9 ml kPa(-1)) in infants with BPD compared to infants without and (iii) these differences are not influenced by early Ambroxol treatment. If the process of BPD development is induced, early Ambroxol treatment has no influence on impaired lung function at day 28. (+info)Use of corticosteroids and the outcome of infants with bronchopulmonary dysplasia. (3/452)
Ventilator-dependent premature infants are often treated with dexamethasone. Several trials showed that steroids while improve pulmonary compliance and facilitate extubation, some treated infants may have adverse effects, such as alterations of growth curves. We conducted this retrospective study to evaluate the effects of steroids on mechanical ventilation, oxygen therapy, hospital length stay and mortality, in ventilator-dependent infants with bronchopulmonary dysplasia (BPD) (defined as the need of oxygen supplementation at 28 days of life). Twenty-six newborns with BPD were evaluated during 9 - 42 days postpartum (mean = 31 days) and were divided into two groups: Group I - 14 newborns that did not receive dexamethasone, and Group II - 12 newborns that received dexamethasone at 14 - 21 days of life. Dexamethasone was given at a dose of 0.25 mg per kilogram of body weight twice daily intravenously for 3 days, after which the dose was tapered. RESULTS: There were no statistically significant differences in the mean length of mechanical ventilation (Group I - 37 days, Group II - 35 days); oxygen supplementation (Group I - 16 days, Group II - 29 days); hospital stay (Group I - 72 days, Group II - 113 days); mortality (Group I - 35.7%, Group II - 41.6%). At birth, Group II was lighter (BW: Group I - 1154 grams +/- 302, Group II - 791 grams +/- 165; p < 0.05) and smaller (height: Group I - 37.22 cm +/- 3.3, Group II - 33.5 +/- 2.4; p< 0.05) than Group I. At 40 weeks, there were no statistically significant differences between groups in relation to anthropometric measurements. CONCLUSIONS: The use of corticosteroids in bronchopulmonary dysplasic infants may influence the somatic growth during its use. However, after its suspension, a recovery seems to occur, suggesting that its influence could be transitory. (+info)Cytokine response during hyperoxia: sequential production of pulmonary tumor necrosis factor and interleukin-6 in neonatal rats. (4/452)
BACKGROUND: Exposure of newborn animals to high concentrations of oxygen leads to diffuse alveolar damage similar to that seen in bronchopulmonary dysplasia in human infants. Therefore, neonatal rats are a suitable practical model of hyperoxic lung damage in human infants. OBJECTIVE: To determine the involvement of tumor necrosis factor-alpha and interleukin-6 in lung injury in neonatal rats exposed to 100% O2 concentration. METHODS: A randomized controlled study was designed in which litters of term Sprague-Dawley rat pups were assigned to experimental or control groups. The pups in the experimental group were placed in 100% O2 from birth for 9 days, while the control pups were placed in room air. Twelve to 15 pups from each group were sacrificed on day 1, 3, 6, 9 and 13 after birth for bronchoalveolar lavage collection and lung histologic study. The bronchoalveolar lavage fluid was assayed for TNF alpha and IL-6. RESULTS: Newborn rats exposed to 100% O2 for the first 9 days of life showed severe pulmonary edema and hypercellularity on days 1 and 3, which then improved to nearly complete resolution on days 6 and 9. Pulmonary TNF alpha was produced early on O2 exposure (day 3) and pulmonary IL-6 later (days 6 and 9). CONCLUSIONS: Hyperoxia induces sequential production of pulmonary TNF alpha and IL-6, which corresponds to the severity of the pathological findings and the known inflammatory and anti-inflammatory role of these cytokines. (+info)Birth weight <1501 g and respiratory health at age 14. (5/452)
AIMS: To determine the respiratory health in adolescence of children of birth weight <1501 g, and to compare the results with normal birthweight controls. METHODS: Prospective cohort study of children born in the Royal Women's Hospital, Melbourne. Two cohorts of preterm children (86 consecutive survivors 500-999 g birth weight, and 124 consecutive survivors 1000-1500 g birth weight) and a control group of 60 randomly selected children >2499 g birth weight were studied. Children were assessed at 14 years of age. A paediatrician determined the clinical respiratory status. Lung function was measured according to standard guidelines. RESULTS: Of 180 preterm children seen at age 14, 42 (23%) had bronchopulmonary dysplasia (BPD) in the newborn period. Readmission to hospital for respiratory ill health was infrequent in all groups and the rates of asthma were similar (15% in the 500-999 g birth weight group, 21% in the 1000-1500 g birth weight group, 21% in controls; 19% BPD, 18% no BPD). Overall, lung function was mostly within the normal range for all cohorts; few children had lung function abnormalities in clinically significant ranges. However, the preterm children had significantly lower values for variables reflecting flow. Lung function in children of 500-999 g birth weight was similar to children of 1000-1500 g birth weight. Preterm children with BPD had significantly lower values for variables reflecting flow than children without BPD. CONCLUSIONS: The respiratory health of children of birth weight <1501 g at 14 years of age is comparable to that of term controls. (+info)Chronic pulmonary insufficiency in children and its effects on growth and development. (6/452)
Conditions leading to chronic pulmonary insufficiency can affect infants and children. These can lead to growth failure and delayed development. Among the most common and severe of these are bronchopulmonary dysplasia (BPD) and cystic fibrosis. In addition to the respiratory consequences of these diseases, there is ample evidence that they lead to decreased growth as a result of decreased energy intake and increased energy expenditure. Furthermore, there is evidence that infants with BPD may also have delayed development, independent of the effects of their prematurity. Enhancing the long-term outlook for these conditions may therefore require consideration of both improved pulmonary management and aggressive nutritional management to limit growth failure and potentially enhance developmental outcome. Specific micronutrient supplementation, such as antioxidant therapy, may also enhance pulmonary and nutritional status. (+info)Special nutritional needs of infants for prevention of and recovery from bronchopulmonary dysplasia. (7/452)
Extremely low birth weight infants who develop severe respiratory disease may have special nutrient requirements imposed by a combination of enhanced utilization of nutrients or the need for epithelial cell repair resulting from the disease process, as well as to support catch-up growth. Inositol, free fatty acids, vitamin E and vitamin A are proposed as nutrients for which infants at risk of chronic pulmonary insufficiency may have special requirements. Of these nutrients, only for vitamin A does suggestive evidence exist that high doses when given intramuscularly may reduce the incidence of death or chronic lung disease. Exogenous steroid therapy (dexamethasone), which is often used to improve pulmonary compliance in ventilated premature infants, may compromise vitamin A status and induce restricted somatic and bone mineral growth. Supplemental nutrition by means of enriched infant formulas has provided benefits in growth and bone mass accretion to infants recovering from bronchopulmonary dysplasia up to 3-mo corrected age. This growth advantage was not sustained over the subsequent 9 mo, suggesting that prolonged nutritional support is required until catch-up growth is complete. Further studies are required to delineate the needs for specific nutrients such as antioxidant vitamins and minerals or vitamin A that may play a role in preventing severe chronic lung disease in premature infants. As well, the role of supplemental nutrition (beyond the requirements of term infants) to support catch-up growth and maintenance during the critical stages of early development requires further investigation before evidence-based nutrient recommendations can be developed for this special population of infants. (+info)Is there a role for antioxidant therapy in bronchopulmonary dysplasia? (8/452)
Bronchopulmonary dysplasia (BPD) is a chronic lung disease first described in 1967 as a complication of therapy for premature infants with hyaline membrane disease, and treatment with high concentrations of oxygen was thought to be a major contributor to its development. Thus, interventions to enhance lung antioxidants to prevent the development of BPD were considered appropriate therapeutic strategies. In the last decades, advances in the acute care of premature infants has reduced the reliance on therapy with high concentrations of supplemental oxygen. However, the incidence of BPD has not changed significantly. The changing clinical context in which BPD develops begs the question of whether oxidation is important in the development of BPD and, therefore, whether designing interventions enhancing lung antioxidants is still warranted. This review presents evidence that premature infants that will develop BPD have qualitative and quantitative differences in oxidation of lipids and proteins when compared to infants that do not develop BPD. Such differences in oxidation patterns are the most obvious in the first few days of life. The emerging evidence thus supports the concept that the lung injury process leading to the development of BPD occurs within hours to days of delivery and that oxidation is a major contributor to this pathological process. Unfortunately, early attempts at delivery of antioxidants to the lung have not been successful, perhaps because of an inability to deliver antioxidants in a timely manner to the areas in the lung in which deleterious oxidations are occurring. Further research is necessary to determine both the nature and the location of the oxidative events that lead to the development of early lung injury, so that more appropriate and specific antioxidant interventions can be designed. (+info)
Erratum: Serial Changes of Serum Endostatin and Angiopoietin-1 Levels in Preterm Infants with Severe Bronchopulmonary Dysplasia...
Bronchopulmonary Dysplasia Treatment Market Research Study for the Period 2017-2027 - Find Market Research
Impact of a Physiologic Definition on Bronchopulmonary Dysplasia Rates | American Academy of Pediatrics
Best Practices in Severe BPD Treatment - Pediatrics Nationwide
Bronchopulmonary Dysplasia. BPD information. Patient | Patient
Airway administration of corticosteroids for prevention of bronchopulmonary dysplasia in premature infants: a meta-analysis...
Normal pulmonary vascular resistance and left ventricular hypertrophy in young infants with bronchopulmonary dysplasia : An...
Pulmonary and Renal Responses to Furosemide in Infants With Stage III-IV Bronchopulmonary Dysplasia<...
Bronchopulmonary Dysplasia Global Clinical Trials Review, H1, 2013 | Jul 23, 2013 - ReleaseWire
Validation of the National Institutes of Health consensus definition of bronchopulmonary dysplasia | Meta
Efficacy and Safety of Inhaled Budesonide in Very Preterm Infants at Risk for Bronchopulmonary Dysplasia - Full Text View -...
Adrenomedullin regulated by miRNA-574-3p protects premature infants with bronchopulmonary dysplasia | Bioscience Reports |...
Incidence of and risk factors for neonatal morbidity after active perinatal care: extremely preterm infants study in Sweden ...
Bottle-Feeding Behaviors in Preterm Infants With and Without Bronchopulmonary Dysplasia | American Journal of Occupational...
Bronchopulmonary Dysplasia and Perinatal Characteristics Predict 1-Year Respiratory Outcomes in Newborns Born at Extremely Low...
Bronchopulmonary Dysplasia: Past, Current and Future Pathophysiologic Concepts and Their Contribution to Understanding Lung...
MicroRNA-mRNA interactions in a murine model of hyperoxia-induced bronchopulmonary dysplasia | BMC Genomics | Full Text
Drug therapies in bronchopulmonary dysplasia: debunking the myths. - Semantic Scholar
Postnatal Cytomegalovirus Infection and the Risk of Bronchopulmonary Dysplasia
Bronchopulmonary Dysplasia (BPD)
Frontiers | Bronchopulmonary Dysplasia Early Changes Leading to Long-Term Consequences | Medicine
Effect of Hydrocortisone Therapy Initiated 7 to 14 Days After Birth on Mortality or Bronchopulmonary Dysplasia Among Very...
Current Pharmacologic Approaches for Prevention and Treatment of Bronchopulmonary Dysplasia
Home oxygen promotes weight gain in infants with bronchopulmonary dysplasia
Long-Term Effects of Inhaled Budesonide for Bronchopulmonary Dysplasia - Zurich Open Repository and Archive
Nitric oxide to prevent bronchopulmonary dysplasia | Archives of Disease in Childhood
Postnatal use of corticosteroids in bronchopulmonary dysplasia
Bronchopulmonary Dysplasia Treatments | Boston Childrens Hospital
Misdiagnosis of Underlying Causes of Bronchopulmonary dysplasia - RightDiagnosis.com
The Childrens Hospital - ZheJiang University School Of Medicine
Therapeutic interventions and short-term outcomes for infants with sev by Michael A. Padula, Theresa R. Grover et al.
Fatores maternos e neonatais na incidência de displasia broncopulmonar em recém-nascidos de muito baixo peso
DBP Definicion
RePub, Erasmus University Repository:
Preeclampsia and risk of developing bronchopulmonary dysplasia in very preterm neonates
Bronchopulmonary. Causes, symptoms, treatment Bronchopulmonary
Genes Associated With Bronchopulmonary Dysplasia and Retinopathy of Prematurity - Full Text View - ClinicalTrials.gov
Bronchopulmonary Dysplasia - Five More Questions That You Should Ask Your Doctor
Bronchopulmonary Dysplasia - NORD (National Organization for Rare Disorders)
Bronchopulmonary Dysplasia in Very Low Birth Weight Subjects and Lung Function in Late Adolescence | American Academy of...
Bronchopulmonary Dysplasia | CTD
Interleukin-4 and 13 concentrations in infants at risk to develop Bronchopulmonary Dysplasia | BMC Pediatrics | Full Text
Worldwide Business with kathy ireland®: See Airway Therapeutics Share Their Innovative Research Used to Prevent...
Clinical Trial Evaluating the Effect of Prolact CR(R) on Length of Stay and Bronchopulmonary Dysplasia Among Very Low Birth...
Bronchopulmonary Dysplasia | Pediatrics Clerkship | The University of Chicago
Most recent papers with the keyword Dysplasia bronchopulmonary | Read by QxMD
Mechanisms of Lung Injury in a Mouse Model of Bronchopulmonary Dysplasia
Lung function and bronchial responsiveness measured by forced oscillometry after bronchopulmonary dysplasia. | Archives of...
Urinary leukotriene E<sub>4</sub> excretion during the first month of life and subsequent bronchopulmonary dysplasia in...
Increased energy intake for preterm infants with (or developing) bronchopulmonary dysplasia/ chronic lung disease | Cochrane
Inhaled versus systemic corticosteroids for the treatment of bronchopulmonary dysplasia in ventilated very low birth weight...
Bronchopulmonary - definition of bronchopulmonary by The Free Dictionary
Medial basal bronchopulmonary segment S VII | definition of medial basal bronchopulmonary segment S VII by Medical dictionary
Jichao Chen Laboratory - Current Research | MD Anderson Cancer Center
RePub, Erasmus University Repository:
Preventing bronchopulmonary dysplasia: new tools for an old challenge
chronic lung disease definition
Systematic review and meta-analysis of early postnatal dexamethasone for prevention of chronic lung disease
The Role of Hydrocortisone in the Management of Bronchopulmonary Dysplasia - PortSaid Neonatology Group
Emphysema in young adult survivors of moderate-to-severe bronchopulmonary dysplasia | European Respiratory Society
Fluid Administration and Bronchopulmonary Dysplasia: The Lack of an Association | JAMA Pediatrics | JAMA Network
Chest computed tomography findings in bronchopulmonary dysplasia and correlation with lung function | ADC Fetal & Neonatal...
Best Bronchopulmonary Amyloidosis Doctor in Bangalore, Bronchopulmonary Amyloidosis Doctors | Credihealth
Plus it
Consequences of early postnatal lipopolysaccharide exposure on developing lungs in mice<...
Pesquisa | Portal Regional da BVS
Intermittent hypoxia during recovery from neonatal hyperoxic lung injury causes long-term impairment of alveolar development: A...
Die Börsengurus • Thema anzeigen - Zitate
Hey Doc
Most recent papers with the keyword Brostrom | Read by QxMD
The significance of IL-1β +3953C>T, IL-6 -174G>C and -596G>A, TNF-α -308G>A gene polymorphisms and 86 bp variable number tandem...
Caffeine therapy for apnea of prematurity
Plus it
Nutrients | Free Full-Text | Nutrients and Microbiota in Lung Diseases of Prematurity: The Placenta-Gut-Lung Triangle
Lung function after extremely preterm birth-A population-based cohort study (EXPRESS)
BPD Center | CPIR
Retinopathy of prematurity in Korean infants with birthweight greater than 1500 g | British Journal of Ophthalmology
Vasculature is a determinant of epithelial morphogenesis
- Indiana University School of Medicine
Increasing airway obstruction from 8 to 18 years in extremely preterm/low-birthweight survivors born in the surfactant era |...
Administration | Department of Pediatrics | CWRU
USA and Canada RX: Viagra cialis candian pharmacy safe lowest price guaranteed!
Alpha | Upstate Patient Care |SUNY Upstate Medical University
Little but mighty « ...
Achat viagra en ligne quebec in revatio instead of viagra
Childrens Hospital Oakland doctors revolt against UCSF partnership
Figures and data in Pdgfra marks a cellular lineage with distinct contributions to myofibroblasts in lung maturation and injury...
Books Content - INDIAN JOURNAL OF PEDIATRICS
AT-100<...
Bronchopulmonary Dysplagia: Treatment, Diet and Home Remedies - mTatva Health-PIE
Bronchopulmonary arterial shunting without anatomic anastomosis in the dog. | Circulation Research
Anterior basal (bronchopulmonary) segment [S VIII] definition | Drugs.com
Dysplasia - Wikipedia
Krames Online - Chronic Lung Disease: Notes for Family and Friends
Living with Chronic Lung Disease
Living with Chronic Lung Disease
PNNL: From Omics Novel Glimpses into Early Lung Development
Prospective study to evaluate the kind of prone position concerning nursing, pulmonary outcome and material and personnel...
Oxygen toxicity
Bronchopulmonary dysplasia is reversible in the early stages by use of break periods on lower pressures of oxygen, but it may ... Bronchopulmonary dysplasia is among the most common complications of prematurely born infants and its incidence has grown as ... Bronchopulmonary dysplasia was first described by Northway in 1967, who outlined the conditions that would lead to the ... Diagnosis of bronchopulmonary dysplasia in newborn infants with breathing difficulties is difficult in the first few weeks. ...
Infant respiratory distress syndrome
Bronchopulmonary dysplasia". The New England Journal of Medicine. 276 (7): 357-68. doi:10.1056/NEJM196702162760701. PMID ... Chronic lung disease, including bronchopulmonary dysplasia, is common in severe RDS. The etiology of BPD is problematic and may ... Bubble CPAP Bronchopulmonary dysplasia Pulmonary hypoplasia Surfactant metabolism dysfunction Surfactant therapy Wilson-Mikity ... to successfully decrease the use of mechanical ventilation and lower the incidence of bronchopulmonary dysplasia (BPD). Since ...
Pulmonary hygiene
Goodman G (2007). "Chronic pulmonary disease: Bronchopulmonary dysplasia". In Perkin RM, Swift JD, Dale AN, Anas NG (eds.). ...
Neonatal intensive care unit
Complications of extreme prematurity may include intracranial hemorrhage, chronic bronchopulmonary dysplasia (see Infant ...
Health consequences of the Deepwater Horizon oil spill
PAMR1 has been associated with bronchopulmonary dysplasia. It is thought to play an important role in respiratory physiology. ...
Christian P. Speer
Inflammatory Mechanisms in Bronchopulmonary Dysplasia. In: Bronchopulmonary Dysplasia, Abman SH (Ed.) Informa Healthcare, New ... the bronchopulmonary dysplasia (BPD). These findings have opened the way for various anti-inflammatory therapeutic strategies. ... of pulmonary inflammation and increased microvascular permeability during the development of bronchopulmonary dysplasia: a ...
Prohibition of drugs
Caffeine is used to treat bronchopulmonary dysplasia. In most cultures, caffeine in the form of coffee or tea is unregulated. ...
Low birth weight
Kalikkot Thekkeveedu, Renjithkumar; Guaman, Milenka Cuevas; Shivanna, Binoy (November 2017). "Bronchopulmonary dysplasia: A ... while comorbidities such as bronchopulmonary dysplasia may increase them. Daily weight gain can reveal whether a VLBW newborn ...
氧气中毒 - 维基百科,自由的百科全书
Bronchopulmonary Dysplasia. eMedicine. 2009-03-11 [2009-06-29].. - Concise clinical overview with extensive references. ...
Václav Vojta
"Improved lung function by Vojta-therapy in bronchopulmonary dysplasia". ResearchGate. "Recipients of Medal of Merit" (PDF). ... Vojta Therapy has been used to treat cerebral palsy, peripheral paralysis of the arms and legs, hip dysplasia, and problems in ...
Caffeine
... is used in: Bronchopulmonary dysplasia in premature infants for both prevention and treatment. It may improve weight ... It can treat and prevent the premature infant breathing disorders bronchopulmonary dysplasia of prematurity and apnea of ... Kugelman A, Durand M (December 2011). "A comprehensive approach to the prevention of bronchopulmonary dysplasia". Pediatric ...
Pulmonary interstitial emphysema
Bronchopulmonary dysplasia Chalak LF, Kaiser JR, Arrington RW (2007). "Resolution of pulmonary interstitial emphysema following ... of PIE the length of time of mechanical ventilation needed may increase and the incidence of bronchopulmonary dysplasia becomes ...
Chest radiograph
increased (e.g., Langerhans cell histiocytosis, lymphangioleiomyomatosis, cystic fibrosis, allergic bronchopulmonary ... A chest radiograph showing bronchopulmonary dysplasia. *. A chest film after insertion of an implantable cardioverter- ...
Wilson-Mikity syndrome
It is closely related to bronchopulmonary dysplasia (BPD), differing mainly in the lack of prior ventilatory support. All the ... Hodgman JE (Dec 2003). "Relationship between Wilson-Mikity syndrome and the new bronchopulmonary dysplasia". Pediatrics. 112 (6 ... Infant respiratory distress syndrome Bronchopulmonary dysplasia Chronic lung disease[disambiguation needed] (CLD) Retrolental ...
Analeptic
Bronchopulmonary dysplasia is common in infants with low birth weight (. ... Ample research also suggests that caffeine significantly reduces the occurrence of bronchopulmonary dysplasia, which is a ... and bronchopulmonary dysplasia in newborn infants. Caffeine is a weak bronchodilator, which explains the relief of the effects ...
Endothelial colony forming cell
A low number of ECFCs has been identified as a risk factor for infant diseases such as bronchopulmonary dysplasia. ECFCs can ... "Cord blood angiogenic progenitor cells are decreased in bronchopulmonary dysplasia". Eur. Respir. J. 40 (6): 1516-22. doi: ...
Lysozyme
Reduced lysozyme levels have been associated with bronchopulmonary dysplasia in newborns. Piglets fed with human lysozyme milk ... association with the development of bronchopulmonary dysplasia". The Journal of Pediatrics. 121 (2): 262-70. doi:10.1016/S0022- ...
Yoon Bo-hyun
... cerebral palsy and bronchopulmonary dysplasia, seem to be initiated before birth in some, and can be prevented and treated from ... and the risk for the development of bronchopulmonary dysplasia". American Journal of Obstetrics and Gynecology. 177 (4): 825-30 ... "A systemic fetal inflammatory response and the development of bronchopulmonary dysplasia". American Journal of Obstetrics and ... that intrauterine infection/inflammation is an important risk factor for the development of bronchopulmonary dysplasia which is ...
Continuous positive airway pressure
It is associated with a decrease in the incidence of bronchopulmonary dysplasia. In some preterm infants whose lungs have not ...
Chronic obstructive pulmonary disease
Less common conditions that may present similarly include bronchopulmonary dysplasia and obliterative bronchiolitis. Chronic ... Previously it has been known by a number of different names, including chronic obstructive bronchopulmonary disease, chronic ...
Preterm birth
Babies born before 32 weeks probably have a lower risk of death from bronchopulmonary dysplasia if they have CPAP immediately ... previously called bronchopulmonary dysplasia or BPD). Gastrointestinal and metabolic issues can arise from neonatal ... Jaundice of Prematurity Atrial septal defects commonly seen in babies with bronchopulmonary dysplasia because their lungs are ...
Oxygen toxicity
Bronchopulmonary dysplasia". New England Journal of Medicine. 276 (7): 357-68. doi:10.1056/NEJM196702162760701. PMID 5334613.. ... Bronchopulmonary dysplasia is reversible in the early stages by use of break periods on lower pressures of oxygen, but it may ... "How is bronchopulmonary dysplasia diagnosed?". U.S. Department of Health & Human Services. Retrieved 28 September 2008.. ... Bronchopulmonary dysplasia is among the most common complications of prematurely born infants and its incidence has grown as ...
Exhaled nitric oxide
Low levels have been found in primary ciliary dyskinesia, bronchopulmonary dysplasia, and pulmonary arterial hypertension. In ...
Bubble CPAP
It is also associated with a decreased incidence of bronchopulmonary dysplasia (BPD) compared to mechanical ventilation. Not ...
Mycoplasma
... s are associated with infant respiratory distress syndrome, bronchopulmonary dysplasia, and intraventricular ...
Ureaplasma urealyticum
Some patients have given birth to children subjected to bronchopulmonary dysplasia, Intraventricular hemorrhage, and ...
Palivizumab
... children less than two years of age and requiring treatment for bronchopulmonary dysplasia within the last six months; children ...
Chorioamnionitis
Long-term infant complications like bronchopulmonary dysplasia, cerebral palsy, and Wilson-Mikity syndrome have been associated ...
Lucinactant
05-23-2006 Prevention of bronchopulmonary dysplasia in premature infants 10-21-2005 Treatment of bronchopulmonary dysplasia in ... October 1999). "Bronchopulmonary segmental lavage with Surfaxin (KL(4)-surfactant) for acute respiratory distress syndrome". ...
Neonatal intensive care unit
Common diagnoses and pathologies in the NICU include: Anemia Apnea Bradycardia Bronchopulmonary dysplasia (BPD) Hydrocephalus ... Complications of extreme prematurity may include intracranial hemorrhage, chronic bronchopulmonary dysplasia (see Infant ...
Neonatal conjunctivitis
Bronchopulmonary dysplasia. Cardiovascular. *Pneumopericardium. *Persistent fetal circulation. Haemorrhagic and. hematologic ...
Chronic obstructive pulmonary disease
Less common conditions that may present similarly include bronchopulmonary dysplasia and obliterative bronchiolitis.[80] ... including chronic obstructive bronchopulmonary disease, chronic obstructive respiratory disease, chronic airflow obstruction, ...
Necrotizing enterocolitis
Bronchopulmonary dysplasia. Cardiovascular. *Pneumopericardium. *Persistent fetal circulation. Haemorrhagic and. hematologic ...
Erb's palsy
Bronchopulmonary dysplasia. Cardiovascular. *Pneumopericardium. *Persistent fetal circulation. Haemorrhagic and. hematologic ...
Stillbirth
Bronchopulmonary dysplasia. Cardiovascular. *Pneumopericardium. *Persistent fetal circulation. Haemorrhagic and. hematologic ...
Pulmonary hypertension
Allergic bronchopulmonary aspergillosis. *Hamman-Rich syndrome. *Idiopathic pulmonary fibrosis. *Sarcoidosis. *Vaping- ...
Tüümus - Vikipeedia
"Accelerated Thymic Maturation and Autoreactive T Cells in Bronchopulmonary Dysplasia", American Journal of Respiratory and ...
Hemolytic disease of the newborn
Bronchopulmonary dysplasia. Cardiovascular. *Pneumopericardium. *Persistent fetal circulation. Haemorrhagic and. hematologic ...
Placental disease
Bronchopulmonary dysplasia. Cardiovascular. *Pneumopericardium. *Persistent fetal circulation. Bleeding and. hematologic ...
Pleural disease
Bronchopulmonary dysplasia. Cardiovascular. *Pneumopericardium. *Persistent fetal circulation. Haemorrhagic and. hematologic ...
ಪಲ್ಮನರಿ ಎಂಬಾಲಿಸಮ್ (ಶ್ವಾಸಕೋಶದ ಧಮನಿಬಂಧ) - ವಿಕಿಪೀಡಿಯ
ಹೆಚ್ಚಿನ ದೃಷ್ಟಾಂತಗಳಲ್ಲಿ, ಹೆಪ್ಪುಕಾರಕ ವಿರೋಧಿ ಚಿಕಿತ್ಸೆಯು ಚಿಕಿತ್ಸೆಯ ಪ್ರಧಾನ ಆಧಾರವಾಗಿರುತ್ತದೆ. ಹೆಪಾರಿನ್, ಕಡಿಮೆ ಅಣುಗಳಿಗೆ ಸಂಬಂಧಿಸಿದ ತೂಕದ ಹೆಪಾರಿನ್ಗಳು (ಉದಾಹರಣೆಗೆ ಎನಾಕ್ಸೋಪಾರಿನ್ ಮತ್ತು ಡಾಲ್ಟೆಪರಿನ್), ಅಥವಾ ಫಂಡಾಪ್ಯಾರಿನಕ್ಸ್ ಇದು ಮೊದಲ ಹಂತದಲ್ಲಿ ಲೇಪಿಸಲ್ಪಡುತ್ತದೆ, ಹಾಗೆಯೇ ವಾರ್ಫಾರಿನ್, ಆಸಿನೋಕ್ಯುಮರಲ್, ಅಥವಾ ಫೆನ್ಪ್ರೊಕೌಮನ್ ಚಿಕಿತ್ಸೆಯು ಪ್ರಾರಂಭಗೊಳಿಸಲ್ಪಡುತ್ತದೆ (ಇದು ಹಲವಾರು ದಿನಗಳನ್ನು ...
Confined placental mosaicism
Bronchopulmonary dysplasia. Cardiovascular. *Pneumopericardium. *Persistent fetal circulation. Haemorrhagic and. hematologic ...
List of diseases (B)
Bronchopulmonary amyloidosis. *Bronchopulmonary dysplasia. *Brown syndrome. *Brown-Séquard syndrome. Bru[edit]. *Brucellosis ...
Mycoplasma
... bronchopulmonary dysplasia, and intraventricular hemorrhage in preterm infants.[3] ...
Prohibition of drugs
Caffeine is used to treat bronchopulmonary dysplasia. In most cultures, caffeine in the form of coffee or tea is unregulated. ...
ढाँचा:Pediatric conditions originating in the perinatal period - विकिपिडिया
Bronchopulmonary dysplasia ...
Bullous pemphigoid
Spondyloepiphyseal dysplasia congenita. *Spondyloepimetaphyseal dysplasia, Strudwick type. *Kniest dysplasia (see also C2/11) ...
Continuous positive airway pressure
It is associated with a decrease in the incidence of bronchopulmonary dysplasia. In some preterm infants whose lungs haven't ...
Intraventricular hemorrhage
Bronchopulmonary dysplasia. Cardiovascular. *Pneumopericardium. *Persistent fetal circulation. Haemorrhagic and. hematologic ...
Henrik Verder
... has been shown to successfully decrease the use of mechanical ventilation and lower the incidence of bronchopulmonary dysplasia ...
BPD
... may refer to: Borderline personality disorder Bipolar disorder Biliopancreatic diversion Bronchopulmonary dysplasia Bharat ...
Bronchopulmonary Dysplasia (BPD)
Babies who are born prematurely or who experience respiratory problems shortly after birth are at risk for bronchopulmonary ... Bronchopulmonary dysplasia (brahn-ko-PUL-moh-nair-ee dis-PLAY-zhee-uh) involves abnormal development of lung tissue. It most ... No available medical treatment can immediately cure bronchopulmonary dysplasia. Treatment is focused on supporting the ... "Dysplasia" means abnormal changes in the structure or organization of a group of cells. The cell changes in BPD take place in ...
Bronchopulmonary dysplasia: MedlinePlus Medical Encyclopedia
Bronchopulmonary dysplasia (BPD) is a long-term (chronic) lung condition that affects newborn babies who were either put on a ... Bronchopulmonary dysplasia (BPD) is a long-term (chronic) lung condition that affects newborn babies who were either put on a ... Bronchopulmonary dysplasia. In: Kliegman RM, St. Geme JW, Blum NJ, Shah SS, Tasker RC, Wilson KM, eds. Nelson Textbook of ...
Bronchopulmonary Dysplasia (BPD) (for Parents) - Nemours
Babies who are born prematurely or who experience respiratory problems shortly after birth are at risk for bronchopulmonary ... What Is Bronchopulmonary Dysplasia?. Bronchopulmonary dysplasia (BPD), sometimes called chronic lung disease, is a problem with ... How Is Bronchopulmonary Dysplasia Treated?. No medical treatment can cure bronchopulmonary dysplasia right away. Treatment ... What Happens in Bronchopulmonary Dysplasia?. Babies arent born with the condition. It happens when a baby has been on oxygen ...
Bronchopulmonary dysplasia - Wikipedia
Bronchopulmonary Dysplasia. "Bronchopulmonary Dysplasia". American Lung Association. Retrieved 2020-03-12. Northway Jr, WH; ... "Bronchopulmonary Dysplasia". Patient.info. Retrieved 2 February 2014. Jobe, AH; Bancalari, E (June 2001). "Bronchopulmonary ... Infants with bronchopulmonary dysplasia are often treated with diuretics that decrease fluid in the alveoli where gas exchange ... Bronchopulmonary dysplasia (BPD; formerly chronic lung disease of infancy) is a chronic lung disease in which premature infants ...
Summary Proceedings From the Bronchopulmonary Dysplasia Group | Pediatrics
BPD-bronchopulmonary dysplasia. REFERENCES. *. Jobe AH, Bancalari E. Bronchopulmonary dysplasia. Am J Respir Crit Care Med.2001 ... Bronchopulmonary dysplasia (BPD) is an evolving process of lung injury and recovery that can result in chronic pulmonary ... Prophylaxis of early adrenal insufficiency to prevent bronchopulmonary dysplasia: a multicenter trial. Pediatrics.2004;114 : ... Despite improvements in neonatal care, bronchopulmonary dysplasia (BPD) continues to occur in approximately one third of ...
Postnatal use of corticosteroids in bronchopulmonary dysplasia
... administered systemically improves short-term lung function and outcome of infants with established bronchopulmonary dysplasia ... Postnatal use of corticosteroids in bronchopulmonary dysplasia. Authors. Ann R Stark, MD. Ann R Stark, MD ... Hydrocortisone treatment for bronchopulmonary dysplasia and brain volumes in preterm infants. J Pediatr 2013; 163:666. ... See Pathogenesis and clinical features of bronchopulmonary dysplasia, section on Epidemiology.). The use of postnatal ...
Changing incidence of bronchopulmonary dysplasia. - PubMed - NCBI
Complete Information on Bronchopulmonary Dysplasia
Bronchopulmonary grows the unusual symptom including the rapid breath and the blue blue skin color.Babies who have had ... bronchopulmonary dysplasia are at greater risk for developing recurrent respiratory infections, such as pneumonia.Extra ... The Bronchopulmonary growth exceptionally (BPD) is the chronic pulmonary tuberculosis typically occurs in the extremely low ...
Early inhaled glucocorticoid therapy to prevent bronchopulmonary dysplasia. - PubMed - NCBI
The primary outcome measure was bronchopulmonary dysplasia at 28 days of age. Secondary outcomes included bronchopulmonary ... Early inhaled glucocorticoid therapy to prevent bronchopulmonary dysplasia.. Cole CH1, Colton T, Shah BL, Abbasi S, MacKinnon ... The frequency of bronchopulmonary dysplasia was similar in the two groups: 43 percent in the beclomethasone group and 45 ... Early beclomethasone therapy did not prevent bronchopulmonary dysplasia but was associated with lower rates of use of systemic ...
Bronchopulmonary Dysplasia - NORD (National Organization for Rare Disorders)
Bronchopulmonary dysplasia (BPD) is a chronic respiratory disease that most often occurs in low-weight or premature infants who ... Bronchopulmonary dysplasia can affect both males and females. The exact incidence of BPD is unknown. The National Institutes of ... Bronchopulmonary Dysplasia. NORD gratefully acknowledges Steven H. Abman, MD, Professor, Department of Pediatrics, University ... Response Of Pulmonary Mechanics To Terbutaline In Patients With Bronchopulmonary Dysplasia. D.S. Brudno, et al.; Am J Med Sci ( ...
Bronchopulmonary Dysplasia | BPD | Symptoms, Diagnosis, Treatment
Bronchopulmonary dysplasia (BPD) is a chronic lung disease. It mostly affects babies who are born too early. About 40 percent ... What is Bronchopulmonary Dysplasia?. Bronchopulmonary dysplasia (BPD) is a chronic lung disease. It mostly affects babies who ... What are the goals of treatment of Bronchopulmonary Dysplasia?. The goal is to help the baby grow and develop. Providing ... What are the symptoms of Bronchopulmonary Dysplasia?. The main symptoms are trouble breathing and the need for oxygen or ...
Search of: 'Bronchopulmonary Dysplasia' | 'Antibodies' - Modify Search - ClinicalTrials.gov
Bronchopulmonary Dysplasia (BPD): Symptoms, Diagnosis and Treatment
Bronchopulmonary Dysplasia (BPD) is a term used to describe long-term breathing problems for premature babies. BPD involves ... Bronchopulmonary Dysplasia. Bronchopulmonary dysplasia (BPD) is a term used to describe long-term breathing problems for ... Bronchopulmonary Dysplasia (BPD). Bronchopulmonary Dysplasia (BPD) is a term used to describe long-term breathing problems for ... What is Bronchopulmonary Dysplasia? Bronchopulmonary dysplasia (BPD) is a term used to describe long-term breathing problems ...
Bronchopulmonary Dysplasia | Boston Children's Hospital
Current Pharmacologic Approaches for Prevention and Treatment of Bronchopulmonary Dysplasia
Bronchopulmonary dysplasia (BPD) is a major complication of preterm birth and has serious adverse long-term health consequences ... A. H. Jobe and E. Bancalari, "Bronchopulmonary dysplasia," American Journal of Respiratory and Critical Care Medicine, vol. 163 ... M. M. Laughon, P. Brian Smith, and C. Bose, "Prevention of bronchopulmonary dysplasia," Seminars in Fetal and Neonatal Medicine ... Current Pharmacologic Approaches for Prevention and Treatment of Bronchopulmonary Dysplasia. Kristen Tropea. 1. ,. 2 and Helen ...
Bronchopulmonary Dysplasia | Respiratory Insufficiency - Causes, Clinical features, Management
Bronchopulmonary dysplasia or chronic lung disease of infancy is seen in premature and low birth weight infants. It results ... What is Bronchopulmonary Dysplasia?. Bronchopulmonary dysplasia or chronic lung disease of neonates predominantly affects ... Bronchopulmonary Dysplasia or Respiratory insufficiency Bronchopulmonary dysplasia (BPD) is a chronic lung disease of newborns ... Bronchopulmonary dysplasia (BPD) is defined as the condition that occurs when symptoms of RDS persist for more than one month ...
Morphometric analysis of the lung in bronchopulmonary dysplasia
We studied lung development in children with or without bronchopulmonary dysplasia (BPD) using light microscopic morphometry ... Morphometric analysis of the lung in bronchopulmonary dysplasia Am Rev Respir Dis. 1991 Feb;143(2):391-400. doi: 10.1164/ajrccm ... We studied lung development in children with or without bronchopulmonary dysplasia (BPD) using light microscopic morphometry ...
Bronchopulmonary dysplasia: new becomes old again!
... bronchopulmonary dysplasia (BPD) continues to be a frustrating disease of prematurity. BPD is a disease which is defined oddly ... Bronchopulmonary dysplasia: new becomes old again! Pediatr Res. 2017 Jan;81(1-2):210-213. doi: 10.1038/pr.2016.201. Epub 2016 ... Despite the many advances in neonatology, bronchopulmonary dysplasia (BPD) continues to be a frustrating disease of prematurity ...
Bronchopulmonary Dysplasia Treatments | Boston Children's Hospital
Impact of a Physiologic Definition on Bronchopulmonary Dysplasia Rates | American Academy of Pediatrics
Impact of a Physiologic Definition on Bronchopulmonary Dysplasia Rates. Michele C. Walsh, Qing Yao, Patricia Gettner, Ellen ... Impact of a Physiologic Definition on Bronchopulmonary Dysplasia Rates. Michele C. Walsh, Qing Yao, Patricia Gettner, Ellen ... Impact of a Physiologic Definition on Bronchopulmonary Dysplasia Rates Message Subject (Your Name) has sent you a message from ... Objective. Bronchopulmonary dysplasia (BPD) is the endpoint of many intervention trials in neonatology, yet the outcome measure ...
Frontiers | Biomarkers for Bronchopulmonary Dysplasia in the Preterm Infant | Pediatrics
Bronchopulmonary dysplasia (BPD) is a chronic inflammatory lung disease of very low birth weight (VLBW) preterm infants, ... Bronchopulmonary dysplasia (BPD) is a chronic inflammatory lung disease of very low birth weight (VLBW) preterm infants, ... Prediction of bronchopulmonary dysplasia. Arch Dis Child Fetal Neonatal Ed (2011) 96:F410-6. doi:10.1136/adc.2010.189597 ... Prevention of bronchopulmonary dysplasia: are intratracheal steroids with surfactant a magic bullet? Am J Respir Crit Care Med ...
Bronchopulmonary Dysplasia | Springer for Research & Development
This book provides a comprehensive framework for treatment and management of bronchopulmonary dysplasia. In recent years great ... Oxygen Modulation and Bronchopulmonary Dysplasia: Delivery Room and Beyond Isabel Torres-Cuevas, María Cernada, Antonio Nuñez, ... Bronchopulmonary Dysplasia is an essential volume for all neonatologists, pediatric pulmonologists, and scientists interested ... Noninvasive Ventilation for the Prevention of Bronchopulmonary Dysplasia Louise S. Owen, Brett J. Manley, Vineet Bhandari, ...
Frontiers | Bronchopulmonary Dysplasia Early Changes Leading to Long-Term Consequences | Medicine
Bronchopulmonary Dysplasia (BPD) is characterized by impaired pulmonary development. Triggered by different risk factors ... Bronchopulmonary Dysplasia (BPD) is characterized by impaired pulmonary development. Triggered by different risk factors ... Prediction of bronchopulmonary dysplasia by postnatal age in extremely premature infants. Am J Respir Crit Care Med (2011) 183: ... Bronchopulmonary dysplasia and inflammatory biomarkers in the premature neonate. Arch Dis Child Fetal Neonatal Ed (2008) 93: ...
Bronchopulmonary Dysplasia - Five More Questions That You Should Ask Your Doctor
If your baby has been diagnosed with bronchopulmonary dysplasis, you may wish to ask your physician the following five ... Bronchopulmonary Dysplasia - Five More Questions That You Should Ask Your Doctor By Mamta Singh ... This Bronchopulmonary Dysplasia - Five More Questions That You Should Ask Your Doctor page on EmpowHER Womens Health works ... If your baby has been diagnosed with bronchopulmonary dysplasis, you may wish to ask your physician the following five ...
Bronchopulmonary Dysplasia - Lahey Health
Bronchopulmonary dysplasia. EBSCO DynaMed website. Available at: https://www.dynamed.com/condition/bronchopulmonary-dysplasia ... Bronchopulmonary dysplasia (BPD) is a chronic lung disease that can happen in newborns and babies. It can make it hard to ... Jain D, Bancalari E. Bronchopulmonary dysplasia: clinical perspective. Birth Defects Res A Clin Mol Teratol. 2014 Mar;100(3): ... Bronchopulmonary dysplasia. American Lung Association website. Available at: http://www.lung.org/lung-disease/bronchopulmonary- ...
Thioredoxin Reductase-1 Inhibition Augments Endogenous Glutathione-Dependent Antioxidant Responses in Experimental...
... improves alveolarization in experimental murine bronchopulmonary dysplasia (BPD). Glutathione (GSH) mediates susceptibility to ... S. E. Welty, "Is there a role for antioxidant therapy in bronchopulmonary dysplasia?" The Journal of Nutrition, vol. 131, no. 3 ... E. Bancalari and D. Jain, "Bronchopulmonary dysplasia: can we agree on a definition?" American Journal of Perinatology, vol. 35 ... N. Ambalavanan and W. A. Carlo, "Bronchopulmonary dysplasia: new insights," Clinics in Perinatology, vol. 31, no. 3, pp. 613- ...
Genes Associated With Bronchopulmonary Dysplasia and Retinopathy of Prematurity - Full Text View - ClinicalTrials.gov
Genes Associated With Bronchopulmonary Dysplasia and Retinopathy of Prematurity. The safety and scientific validity of this ... Bronchopulmonary Dysplasia. Respiratory Tract Diseases. Eye Diseases. Ventilator-Induced Lung Injury. Lung Injury. Infant, ... Some premature babies develop bronchopulmonary dysplasia (BPD) and retinopathy of prematurity (ROP). BPD and ROP are long-term ... Trial record 1 of 12 for: bronchopulmonary dysplasia OR neonatal chronic lung disease , Recruiting, Not yet recruiting, ...
Bronchopulmonary dysplasia | Archives of Disease in Childhood
Diagnosing and Treating Bronchopulmonary Dysplasia | American Lung Association
Bronchopulmonary Dysplasia *Learn About Bronchopulmonary Dysplasia *Bronchopulmonary Dysplasia Symptoms, Causes and Risk ... How Bronchopulmonary Dysplasia Is Treated. Several types of drug therapies may be used to treat BPD:. *Diuretics: This class of ... Diagnosing and Treating Bronchopulmonary Dysplasia. There is no specific test for the diagnosis of BPD, nor is there specific ... How Bronchopulmonary Dysplasia Is Diagnosed. The diagnosis of BPD is based on the infants clinical situation, how premature he ...
Bronchopulmonary Dysplasia | Neonatal Care | Mercy Health
Learn about bronchopulmonary dysplasia, including causes, symptoms, diagnosis and treatment from the experts at Mercy Health. ... Causes of bronchopulmonary dysplasia. Factors that contribute to bronchopulmonary dysplasia include:. *Infants who weigh less ... What is bronchopulmonary dysplasia?. Bronchopulmonary dysplasia, or BPD, is a serious lung condition that affects newborns ( ... Treatments for bronchopulmonary dysplasia. The best thing for infants with bronchopulmonary dysplasia is to support their ...
Lung diseasePrematurityRisk of bronchopulmonary dysplasiaManagement of bronchopulmonary dysplasiaDevelop bronchopulmonary dysplasiaPrevent bronchopulmonary dysplasiaClinicalHigh risk for developing bronchopulmonarBiomarkersComplicationPulmonary HypertensionPreterm birthOutcomesKnown as bronchopulmonary dysplasiaDeath or bronchopulmonary dysplasiaDiagnosis of Bronchopulmonary DysplasiaAmong extremely preterm infants2019Premature babiesSevereCure bronchopulmonary dysplasiaTreat bronchopulmonary dysplasiaDiagnose Bronchopulmonary DysplasiaInfants with and without bronchopulmonaryMechanical ventilationTreatment of bronchopulmonaryPrevention of bronchopulmonaryDevelopment of bronchopulmonaryPathogenesis of bronchopulmonaryEpidemiologyHyperoxiaMortalityPostnatal2018PathologySymptomsAbman SHOutcomeChronic respiratoryPredictionNeonatal inte
Lung disease27
- Babies who are born very prematurely or who have respiratory problems shortly after birth are at risk for bronchopulmonary dysplasia (BPD), sometimes called chronic lung disease. (kidshealth.org)
- Bronchopulmonary dysplasia (BPD), sometimes called chronic lung disease, is a problem with how a baby's lung tissue develops. (kidshealth.org)
- Bronchopulmonary dysplasia (BPD) is a chronic lung disease. (nationaljewish.org)
- Long-term respiratory problems faced by babies born prematurely are known, generally, as either bronchopulmonary dysplasia (BPD) chronic lung disease (CLD). (childrenshospital.org)
- Bronchopulmonary dysplasia (BPD) is a chronic lung disease (CLD) that occurs in preterm infants receiving respiratory support with mechanical ventilation or prolonged oxygen supplementation. (aappublications.org)
- Bronchopulmonary dysplasia (BPD) is a chronic lung disease of newborns, often affecting preterm babies. (medindia.net)
- Bronchopulmonary dysplasia or chronic lung disease of neonates predominantly affects preterm babies (born before 37 weeks), especially those born before 28 weeks gestation (7 months gestation). (medindia.net)
- Bronchopulmonary dysplasia (BPD) is a form of chronic lung disease that affects newborns. (lung.org)
- Bronchopulmonary dysplasia (BPD) is a chronic inflammatory lung disease of very-low-birth-weight (VLBW) preterm infants, associated with arrested lung development and a need for supplemental oxygen. (frontiersin.org)
- Neonatal chronic lung disease, i.e., bronchopulmonary dysplasia, is characterized by impaired pulmonary development resulting from the impact of different risk factors including infections, hyperoxia, and mechanical ventilation on the immature lung. (frontiersin.org)
- The neonatal form of chronic lung disease (CLD), also known as bronchopulmonary dysplasia (BPD), is one of the most common forms of CLD in early infancy. (frontiersin.org)
- Bronchopulmonary dysplasia (BPD) is a chronic lung disease that can happen in newborns and babies. (lahey.org)
- Abstract RATIONALE: Bronchopulmonary dysplasia is a heterogeneous lung disease characterized by regions of cysts and fibrosis, but methods for evaluating lung function are limited to whole lung rather than specific regions of interest. (medworm.com)
- Bronchopulmonary dysplasia is chronic lung disease of the neonate that typically is caused by prolonged ventilation and is further defined by age of prematurity and extent of supplemental oxygen requirement. (merckmanuals.com)
- Chronic lung disease (CLD) or bronchopulmonary dysplasia (BPD) is a disease of premature babies who required prolonged support with their breathing and supplemental oxygen. (cochrane.org)
- Bronchopulmonary dysplasia (BPD) is the most common chronic lung disease (CLD) in premature infants. (portlandpress.com)
- Bronchopulmonary dysplasia (BPD) is a type of lung disease that affects premature infants. (nih.gov)
- Bronchopulmonary dysplasia (BPD) is the most prevalent chronic lung disease in infants and presents as a consequence of preterm birth. (eur.nl)
- Bronchopulmonary dysplasia (BPD) as a chronic lung disease affecting preterm infants has been recognized for more than 45 years. (wisepress.com)
- Bronchopulmonary dysplasia (BPD), a chronic lung disease of the newborn, is one of the most common complications of prematurity and treatments for RDS. (pharmiweb.com)
- Bronchopulmonary Dysplasia (BPD) is a lung disease which can be very serious. (breathehealthy.org)
- Carraro S, Filippone M, Da Dalt L, Ferraro V, Maretti M, Bressan S et al (2013) Bronchopulmonary dysplasia: the earliest and perhaps the longest lasting obstructive lung disease in humans. (springer.com)
- Bronchopulmonary dysplasia is a chronic lung disease of premature neonates characterized by arrested pulmonary alveolar development. (biomedcentral.com)
- Three years ago, Stella Kourembanas, MD , and S. Alex Mitsialis, PhD , thought they had a major breakthrough in treating pulmonary hypertension (PH) - dangerously high blood pressure in the pulmonary artery (the vessel that carries blood from the heart to the lungs) - and bronchopulmonary dysplasia (BPD) - a chronic lung disease that can affect babies born prematurely or who were put on a ventilator. (childrenshospital.org)
- Bronchopulmonary Dysplasia (BPD) was classically thought of as a chronic lung disease of children who were born prematurely with low birthweights and who received mechanical ventilation with high pressure and oxygen supplementation to treat respiratory distress syndrome [ 1 ]. (uchicago.edu)
- Prematurely born infants who require mechanical ventilation (MV) frequently develop chronic lung disease known as bronchopulmonary dysplasia (BPD). (biomedcentral.com)
- Bronchopulmonary dysplasia (BPD) is the most common chronic lung disease of infancy and is associated with significant morbidity, mortality and cost. (northwestern.edu)
Prematurity6
- Bronchopulmonary dysplasia (BPD) remains a major complication of prematurity resulting in significant mortality and morbidity despite advances in perinatal care and decline in mortality rates among very low birth weight (VLBW) infants [ 1 ]. (hindawi.com)
- Despite the many advances in neonatology, bronchopulmonary dysplasia (BPD) continues to be a frustrating disease of prematurity. (nih.gov)
- Some premature babies develop bronchopulmonary dysplasia (BPD) and retinopathy of prematurity (ROP). (clinicaltrials.gov)
- Bronchopulmonary dysplasia (BPD) caused by prematurity is associated with more remodeling and fibrosis than asthma, yet symptoms and treatment of these two disorders are similar. (ersjournals.com)
- Bronchopulmonary dysplasia (BPD) is a severe complication of prematurity that impacts survival and neurodevelopment. (springer.com)
- Bronchopulmonary dysplasia (BPD) is a major complication of prematurity. (ersjournals.com)
Risk of bronchopulmonary dysplasia1
- and to develop a Web-based estimator using readily available clinical information to predict risk of bronchopulmonary dysplasia or death. (rti.org)
Management of bronchopulmonary dysplasia4
- See 'Prevention of bronchopulmonary dysplasia' and 'Management of bronchopulmonary dysplasia' . (uptodate.com)
- Inositol, vitamin E and selenium may have a therapeutic effect in the prevention and management of bronchopulmonary dysplasia. (greenmedinfo.com)
- This book provides a comprehensive framework for treatment and management of bronchopulmonary dysplasia. (springer.com)
- Zurück zum Zitat Bhandari A, Panitch H. An update on the post-NICU discharge management of bronchopulmonary dysplasia. (springermedizin.de)
Develop bronchopulmonary dysplasia4
- Sometimes, babies that require life-saving treatment to breathe develop bronchopulmonary dysplasia. (mercy.com)
- The earlier the baby is born, the more likely it is they might develop bronchopulmonary dysplasia. (mercy.com)
- Background: One-third to one-half of all infants born before the 28th week of gestation develop bronchopulmonary dysplasia (BPD). (harvard.edu)
- An exaggerated inflammatory response occurs in the first few days of life in infants who subsequently develop bronchopulmonary dysplasia (BPD). (biomedcentral.com)
Prevent bronchopulmonary dysplasia5
- There is evidence to show that steroids given to babies less than 8 days old can prevent bronchopulmonary dysplasia. (wikipedia.org)
- Early inhaled glucocorticoid therapy to prevent bronchopulmonary dysplasia. (nih.gov)
- The safety and efficacy of inhaled glucocorticoid therapy for asthma stimulated its use in infants to prevent bronchopulmonary dysplasia. (nih.gov)
- Early beclomethasone therapy did not prevent bronchopulmonary dysplasia but was associated with lower rates of use of systemic glucocorticoid therapy and mechanical ventilation. (nih.gov)
- Uncertainly prevails with regard to the use of inhalation or instillation steroids to prevent bronchopulmonary dysplasia in preterm infants. (biomedcentral.com)
Clinical13
- Clinical trials have shown that postnatal corticosteroid therapy administered systemically improves short-term lung function and outcome of infants with established bronchopulmonary dysplasia (BPD), and reduces the risk of BPD in high-risk preterm infants. (uptodate.com)
- See 'Pathogenesis and clinical features of bronchopulmonary dysplasia', section on 'Epidemiology' . (uptodate.com)
- Postnatal corticosteroid administration is an area of intense clinical interest because of the desire to reduce the incidence and severity of bronchopulmonary dysplasia (BPD) ( table 1 ). (uptodate.com)
- Rationale: Benefits of identifying risk factors for bronchopulmonary dysplasia in extremely premature infants include providing prognostic information, identifying infants likely to benefit from preventive strategies, and stratifying infants for clinical trial enrollment. (rti.org)
- GlobalData's clinical trial report, Bronchopulmonary Dysplasia Global Clinical Trials Review, H1, 2013" provides data on the Bronchopulmonary Dysplasia clinical trial scenario. (sbwire.com)
- This report provides elemental information and data relating to the clinical trials on Bronchopulmonary Dysplasia. (sbwire.com)
- The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Bronchopulmonary Dysplasia. (sbwire.com)
- Pulmonary artery hypertension in formerly premature infants with bronchopulmonary dysplasia: clinical features and outcomes in the surfactant era. (springer.com)
- Background: Despite advances in clinical care, the incidence of bronchopulmonary dysplasia (BPD) remains high in premature infants. (biomedsearch.com)
- Effect of Sustained Inflations vs Intermittent Positive Pressure Ventilation on Bronchopulmonary Dysplasia or Death Among Extremely Preterm Infants: The SAIL Randomized Clinical Trial. (edu.au)
- 1. A method for improving one or more clinical outcomes in an infant with bronchopulmonary dysplasia (BPD) or at risk of developing BPD, comprising administering to said infant a human milk composition fortified with a pasteurized human milk cream composition, wherein the pasteurized human milk cream composition comprises about 2.0 kcal/ml to about 3.0 kcal/ml. (patents.com)
- Bronchopumonary dysplasia (BPD) was first described by Northway in 1967 (1) reporting clinical and radiographic changes in the lungs of preterm infants who had respiratory distress syndrome (RDS) and who were treated with oxygen and mechanical ventilation. (signavitae.com)
- CONCLUSION: Both bronchopulmonary dysplasia and perinatal clinical data accurately identify ELGANs at risk for persistent and severe respiratory morbidity at 1 year. (duke.edu)
High risk for developing bronchopulmonar1
- Premature infants are at high risk for developing bronchopulmonary dysplasia (BPD), characterized by chronic inflammation and inhibition of lung development, which we have recently identified as being modulated by microRNAs (miRNAs) and alterations in the airway microbiome. (jci.org)
Biomarkers1
- Early identification of bronchopulmonary dysplasia using novel biomarkers by proteomic screening. (springermedizin.de)
Complication7
- Bronchopulmonary dysplasia (BPD) is a major complication of preterm birth and has serious adverse long-term health consequences. (hindawi.com)
- Bronchopulmonary dysplasia (BPD) is a common complication in preterm infants. (cochrane.org)
- Other conditions that might have Bronchopulmonary dysplasia as a complication may, potentially, be an underlying cause of Bronchopulmonary dysplasia. (rightdiagnosis.com)
- Other conditions that might have Bronchopulmonary dysplasia as a complication might be potential underlying conditions. (rightdiagnosis.com)
- The development of pulmonary hypertension (PH) is a serious complication of bronchopulmonary dysplasia (BPD) among infants born at extremely low gestational ages. (luriechildrens.org)
- BACKGROUND AND OBJECTIVES With the increasing survival of preterm infants, pulmonary hypertension (PH) related to bronchopulmonary dysplasia (BPD) has become an important complication. (semanticscholar.org)
- Bronchopulmonary dysplasia (BPD) is a serious complication associated with preterm birth. (plos.org)
Pulmonary Hypertension6
- Mirza H, Ziegler J, Ford S, Padbury J, Tucker R, Laptook A. Pulmonary hypertension in preterm infants: prevalence and association with bronchopulmonary dysplasia. (springer.com)
- Berkelhamer SK, Mestan KK, Steinhorn RH (2013) Pulmonary hypertension in bronchopulmonary dysplasia. (springer.com)
- An Echocardiographic Screening Program Helps to Identify Pulmonary Hypertension in Extremely Low Birthweight Infants with and without Bronchopulmonary Dysplasia: A Single-Center Experience. (semanticscholar.org)
- Pulmonary hypertension (PH) frequently occurs in infants with bronchopulmonary dysplasia (BPD), causing increased mortality and right ventricular (RV) dysfunction that persists into adulthood. (readbyqxmd.com)
- Screening echocardiogram performed at the time of bronchopulmonary dysplasia (BPD) diagnosis can help identify infants at higher risk for developing clinically significant, long-term pulmonary hypertension (PH), particularly when coupled with serum brain natriuretic peptide (BNP) values, according to the results of a retrospective longitudinal study published in Pediatric Cardiology . (thecardiologyadvisor.com)
- Screening echocardiography and brain natriuretic peptide levels predict late pulmonary hypertension in infants with bronchopulmonary dysplasia [published online April 1, 2019]. (thecardiologyadvisor.com)
Preterm birth1
- Improved survival following extreme preterm birth complicated by bronchopulmonary dysplasia (BPD) is resulting in an increasing number of affected infants surviving to adulthood. (ersjournals.com)
Outcomes4
- Secondary outcomes included bronchopulmonary dysplasia at 36 weeks of postmenstrual age, the need for systemic glucocorticoid therapy, the need for bronchodilator therapy, the duration of respiratory support, and death. (nih.gov)
- We compared neurodevelopmental outcomes of extremely low birth weight (ELBW) infants with and without bronchopulmonary dysplasia (BPD), using the physiologic definition. (rti.org)
- A lung condition called bronchopulmonary dysplasia (BPD) is a major cause of poor outcomes and death for premature infants. (checkorphan.org)
- Bronchopulmonary Dysplasia and Perinatal Characteristics Predict 1-Year Respiratory Outcomes in Newborns Born at Extremely Low Gestational Age: A Prospective Cohort Study. (duke.edu)
Known as bronchopulmonary dysplasia1
- Babies who are born early (preterm) often suffer from long-lasting breathing problems known as bronchopulmonary dysplasia , which can lead to poor health in childhood and adulthood. (cochrane.org)
Death or bronchopulmonary dysplasia1
- The primary outcome was death or bronchopulmonary dysplasia, confirmed by means of standardized oxygen-saturation monitoring, at a postmenstrual age of 36 weeks. (uzh.ch)
Diagnosis of Bronchopulmonary Dysplasia2
- With a diagnosis of Bronchopulmonary dysplasia, it is important to consider whether there is an underlying condition causing Bronchopulmonary dysplasia. (rightdiagnosis.com)
- The diagnosis of bronchopulmonary dysplasia is suspected in infants who were born prematurely, who have received ventilation and/or supplemental oxygen or CPAP for an extended period of time (generally for several weeks or months), who have signs of respiratory distress, and who may still need supplemental oxygen. (msdmanuals.com)
Among extremely preterm infants2
- BACKGROUND Systemic glucocorticoids reduce the incidence of bronchopulmonary dysplasia among extremely preterm infants, but they may compromise brain development. (uzh.ch)
- CONCLUSIONS Among extremely preterm infants, the incidence of bronchopulmonary dysplasia was lower among those who received early inhaled budesonide than among those who received placebo, but the advantage may have been gained at the expense of increased mortality. (uzh.ch)
20191
- May 9, 2019 /PRNewswire/ -- Windtree Therapeutics, Inc. (OTCQB: WINT) today announced the results of a new post-hoc analysis of previously released phase 2 data that suggests AEROSURF® may reduce the overall incidence and severity of bronchopulmonary dysplasia (BPD) in premature infants with respiratory distress syndrome (RDS), regardless of whether or not the infant was ultimately intubated. (pharmiweb.com)
Premature babies4
- Premature babies who need oxygen therapy for more than 28 days are considered to have bronchopulmonary dysplasia. (kidshealth.org)
- Bronchopulmonary Dysplasia (BPD) is a term used to describe long-term breathing problems for premature babies. (nationwidechildrens.org)
- Bronchopulmonary dysplasia is a chronic respiratory infection, which regularly happens in low birth weight or premature babies or newborn babies with intense respiratory distress syndrome who have provided with supplement oxygen or kept in a breathing machine (machine ventilation) for a long time. (apnews.com)
- Most cases of bronchopulmonary dysplasia are seen in premature babies who developed Respiratory Distress Syndrome (also called Hyaline Membrane Disease) or RDS. (breathehealthy.org)
Severe8
- Measurements and Main Results: Bronchopulmonary dysplasia was defined as a categorical variable (none, mild, moderate, or severe). (rti.org)
- MRI Evaluation of Regional Lung Tidal Volumes in Severe Neonatal Bronchopulmonary Dysplasia. (medworm.com)
- METHODS: MRI of 17 non-sedated, quiet-breathing, severe bronchopulmonary dysplasia infants were reconstructed into end-inspiration and end-exp. (medworm.com)
- Young adult survivors of moderate and severe bronchopulmonary dysplasia may be left with residual functional and characteristic structural pulmonary abnormalities, most notably emphysema. (ersjournals.com)
- Bronchopulmonary dysplasia (BPD) is the result of a complex process in which several prenatal and/or postnatal factors interfere with lower respiratory tract development, leading to a severe, lifelong disease. (biomedcentral.com)
- Different lung ultrasound (LUS) scanning protocols have been used and the results in terms of diagnostic accuracy are heterogeneous.What is the diagnostic accuracy of the LUS score to predict moderate-severe bronchopulmonary dysplasia (msBPD)? (onmedica.com)
- Bronchopulmonary dysplasia (BPD) is a chronic lung disorder that occurs most often in infants who were born very premature (delivered before 32 weeks of gestation ) and with a severe lung disorder (such as respiratory distress syndrome ). (msdmanuals.com)
- Bronchopulmonary dysplasia (BPD), defined as oxygen dependence at 36 weeks of postmenstrual age (PMA), is a severe complications of extremely premature infants. (biomedcentral.com)
Cure bronchopulmonary dysplasia2
- No available medical treatment can immediately cure bronchopulmonary dysplasia. (kidshealth.org)
- No medical treatment can cure bronchopulmonary dysplasia right away. (kidshealth.org)
Treat bronchopulmonary dysplasia2
- The report offers an exhaustive analysis of the pipeline molecules under investigation within the defined data collection period to treat bronchopulmonary dysplasia. (apnews.com)
- Policy statement-postnatal corticosteroids to prevent or treat bronchopulmonary dysplasia. (aafp.org)
Diagnose Bronchopulmonary Dysplasia2
- How do you Diagnose Bronchopulmonary Dysplasia? (medindia.net)
- The doctor may diagnose bronchopulmonary dysplasia if the baby still needs oxygen therapy at 36 weeks after conception, or 28 days after birth. (mercy.com)
Infants with and without bronchopulmonary1
- In this study, we aimed to analyze differences in plasma protein abundances between infants with and without bronchopulmonary dysplasia (BPD), to add new insights into a better understanding of the pathogenesis of this disease. (springermedizin.de)
Mechanical ventilation4
- Bronchopulmonary dysplasia (BPD) is a chronic respiratory disease that most often occurs in low-weight or premature infants who have received supplemental oxygen or have spent long periods of time on a breathing machine (mechanical ventilation), such as infants who have acute respiratory distress syndrome. (rarediseases.org)
- Since bronchopulmonary dysplasia (BPD) is also associated with altered lung development and worsens with stimuli including mechanical ventilation, reactive oxygen species, and inflammation, HHIP and FGF10 may be candidate genes. (elsevier.com)
- Sustained inflations and avoidance of endotracheal mechanical ventilation (eMV) are delivery room interventions aimed at preventing bronchopulmonary dysplasia (BPD). (ersjournals.com)
- Bronchopulmonary Dysplasia (BPD) was first described by Northway and colleagues in 1967 as a lung injury in preterm infants resulting from oxygen and mechanical ventilation (1). (fiocruz.br)
Treatment of bronchopulmonary5
- What are the goals of treatment of Bronchopulmonary Dysplasia? (nationaljewish.org)
- BACKGROUND The long-Term effects on neurodevelopment of the use of inhaled glucocorticoids in extremely preterm infants for the prevention or treatment of bronchopulmonary dysplasia are uncertain. (eur.nl)
- Choosing Wisely: Don't prescribe high-dose dexamethasone (0.5mg/kg per day) for the prevention or treatment of bronchopulmonary dysplasia in preterm infants. (aafp.org)
- Thus, they are attractive human cell-based therapies for the treatment of bronchopulmonary dysplasia, chronic obstructive pulmonary disease, ischemic stroke, neuron degenerative diseases, autoimmune diseases, etc. (labroots.com)
- Are inhaled steroids safe and effective for prevention or treatment of bronchopulmonary dysplasia? (readbyqxmd.com)
Prevention of bronchopulmonary2
- CONCLUSIONS Among surviving extremely preterm infants, the rate of neurodevelopmental disability at 2 years did not differ significantly between infants who received early inhaled budesonide for the prevention of bronchopulmonary dysplasia and those who received placebo, but the mortality rate was higher among those who received budesonide. (eur.nl)
- OBJECTIVES: I. Estimate the efficacy of cortisol replacement therapy during the first 12 days of life for prevention of bronchopulmonary dysplasia. (checkorphan.org)
Development of bronchopulmonary3
- Hypercarbia (too much carbon dioxide in the blood) may contribute to the development of bronchopulmonary dysplasia. (wikipedia.org)
- Sirtuin1 in tracheal aspirate leukocytes: possible role in the development of bronchopulmonary dysplasia in premature infants. (biomedsearch.com)
- Objective: To study the association between Sirtuin1 (Sirt1), a class III histone deacetylator, in tracheal aspirate (TA) leukocytes and the development of bronchopulmonary dysplasia (BPD) in premature infants and modulation of Sirt1 with dexamethasone (Dex) use. (biomedsearch.com)
Pathogenesis of bronchopulmonary3
- Pulmonary microvascular injury is associated with the pathogenesis of bronchopulmonary dysplasia (BPD). (springer.com)
- Lung vascular development: implications for the pathogenesis of bronchopulmonary dysplasia. (semanticscholar.org)
- Ventilator-induced lung injury is considered to be a main factor in the pathogenesis of bronchopulmonary dysplasia (BPD). (readbyqxmd.com)
Epidemiology1
- Jensen EA, Schmidt B (2014) Epidemiology of bronchopulmonary dysplasia. (springer.com)
Hyperoxia2
- Curcumin prevents hyperoxia-induced neonatal lung injury long-term, suggesting its potential usefulness in preventing bronchopulmonary dysplasia. (greenmedinfo.com)
- Our previous study revealed a defect in the autophagic flux in the lung tissues of neonatal rats with hyperoxia‑induced bronchopulmonary dysplasia (BPD), but the underlying mechanism remains unknown. (medworm.com)
Mortality3
- Evidence suggests that vitamin A in LBW babies is associated with a reduction in mortality and bronchopulmonary dysplasia.Oxygen therapy at home is recommended in those with significant low oxygen levels. (wikipedia.org)
- Bronchopulmonary dysplasia (BPD) is a leading cause of mortality and morbidity in premature infants with significant lifelong respiratory and neurodevelopmental sequelae into adulthood. (bmj.com)
- Objective To investigate the relationship between postnatal CMV infection and bronchopulmonary dysplasia (BPD) and mortality in a large, multicenter cohort of VLBW infants. (cdc.gov)
Postnatal2
- Because of these issues, the postnatal use of either systemic or inhaled corticosteroids in bronchopulmonary dysplasia is a controversial and continuously evolving subject. (uptodate.com)
- AWeb-based model providing predicted estimates for bronchopulmonary dysplasia by postnatal day is available at https://neonatal.rti.org. (rti.org)
20181
- 2018). Preventing bronchopulmonary dysplasia: new tools for an old challenge. (eur.nl)
Pathology1
- Husain AN, Siddiqui NH, Stocker JT (1998) Pathology of arrested acinar development in postsurfactant bronchopulmonary dysplasia. (springer.com)
Symptoms2
- What are the symptoms of Bronchopulmonary Dysplasia? (nationaljewish.org)
- Bronchopulmonary dysplasia (BPD) is defined as the condition that occurs when symptoms of RDS persist for more than one month after birth . (medindia.net)
Abman SH1
- McEvoy C, Jain L, Schmidt B, Abman SH, Bancalari E, Aschner J. Bronchopulmonary dysplasia: NHLBI Workshop on the Primary Prevention of Chronic Lung Diseases. (springer.com)
Outcome2
- The primary outcome measure was bronchopulmonary dysplasia at 28 days of age. (nih.gov)
- Value of echocardiography in assessing the outcome of bronchopulmonary dysplasia of the newborn. (springer.com)
Chronic respiratory1
- Bronchopulmonary dysplasia is a respiratory condition that presently occurs in preterm neonates and can lead to chronic respiratory problems. (biomedcentral.com)
Prediction1
- describing the prediction of bronchopulmonary dysplasia (BPD) development at 1 week of age. (bmj.com)
Neonatal inte1
- Infants with bronchopulmonary dysplasia may go to the neonatal intensive care unit of the hospital. (mercy.com)